Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Svetlana A. Bugorkova"'
Autor:
Svetlana N. Klyueva, Svetlana A. Bugorkova, Pavel S. Erokhin, Anastasiya Yu. Goncharova, Aleksandr L. Kravtsov
Publikováno v:
Журнал микробиологии, эпидемиологии и иммунобиологии, Vol 101, Iss 3, Pp 372-381 (2024)
Introduction. Based on data on the role of blood erythrocytes in the development and implementation of the vaccine and infectious processes in plague, it was of interest to evaluate changes in erythrocyte surface architecture from the position of sea
Externí odkaz:
https://doaj.org/article/ec2d1720421d4e918166c04135ec7507
Autor:
Anastasiya Yu. Goncharova, Svetlana A. Bugorkova, Ekaterina V. Kislitsina, Valery G. Germanchuk
Publikováno v:
Журнал микробиологии, эпидемиологии и иммунобиологии, Vol 101, Iss 2, Pp 248-258 (2024)
Introduction. Immunomodulatory drugs (IMD) have great potential to increase the nonspecific reactivity of the organism in a set of measures for emergency prevention of plague. The purpose of the work is to evaluate the protective effectiveness of the
Externí odkaz:
https://doaj.org/article/e9dd5fb3e14042a59c43baaf2a8bd4a8
Autor:
Aleksandr L. Kravtsov, Svetlana A. Bugorkova, Svetlana N. Klyueva, Tatyana P. Shmelkova, Vitaly A. Kozhevnikov
Publikováno v:
Журнал микробиологии, эпидемиологии и иммунобиологии, Vol 100, Iss 4, Pp 293-305 (2023)
Introduction. At present, it is important to study the interaction of Staphylococcus aureus with human innate immunity cells under conditions of ex vivo bacteremia modeling, but not only in experiments with phagocytes previously isolated from the blo
Externí odkaz:
https://doaj.org/article/a170086b7f824a9daacdaeb66f2d41ca
Publikováno v:
Журнал микробиологии, эпидемиологии и иммунобиологии, Vol 100, Iss 1, Pp 84-94 (2023)
Introduction. One of the main tasks of specific plague prevention remains the development of vaccines and their application schemes aimed at improving the effectiveness of vaccination through the use of adjuvants and immunomodulators. The purpose
Externí odkaz:
https://doaj.org/article/0f9fce75e1f9425c92426503b606e412
Autor:
Anna Y. Popova, Viacheslav S. Smirnov, Elena E. Andreeva, Elena A. Babura, Sergey V. Balakhonov, Natalia S. Bashketova, Svetlana A. Bugorkova, Maxim V. Bulanov, Natalia. N. Valeullina, Viacheslav. V. Vetrov, Dmitriy. V. Goryaev, Tatyana N. Detkovskaya, Elena B. Ezhlova, Natalia N. Zaitseva, Olga A. Istorik, Irina. V. Kovalchuk, Dmitriy N. Kozlovskikh, Svetlana Y. Kombarova, Olga. P. Kurganova, Alexander. E. Lomovtsev, Lena A. Lukicheva, Ludmila V. Lyalina, Albina. A. Melnikova, Olga M. Mikailova, Alexei K. Noskov, Ludmila N. Noskova, Elena E. Oglezneva, Tatyana P. Osmolovskaya, Marina A. Patyashina, Natalia A. Penkovskaya, Lada V. Samoilova, Tatyana F. Stepanova, Olga E. Trotsenko, Areg A. Totolian
Publikováno v:
Viruses, Vol 13, Iss 8, p 1648 (2021)
The SARS-CoV-2 pandemic, which came to Russia in March 2020, is accompanied by morbidity level changes and can be tracked using serological monitoring of a representative population sample from Federal Districts (FDs) and individual regions. In a lon
Externí odkaz:
https://doaj.org/article/d9653926ac204dd28537a01afd4b01e0
Autor:
Lena A. Lukicheva, Natalia A. Penkovskaya, Elena A. Babura, Areg A. Totolian, Dmitriy N. Kozlovskikh, Anna Y. Popova, Elena B. Ezhlova, Olga A. Istorik, Svetlana A. Bugorkova, Svetlana Y. Kombarova, Ludmila N. Noskova, Viacheslav. V. Vetrov, Alexander. E. Lomovtsev, Viacheslav S. Smirnov, Tatyana P. Osmolovskaya, Lada V. Samoilova, O. E. Trotsenko, A. A. Melnikova, S. V. Balakhonov, O. P. Kurganova, Dmitriy. V. Goryaev, Elena E. Oglezneva, Marina A. Patyashina, Alexei K. Noskov, Maxim V. Bulanov, Natalia. N. Valeullina, O. M. Mikailova, Natalia N. Zaitseva, Tatyana F. Stepanova, Natalia S. Bashketova, Ludmila V. Lyalina, Irina V. Kovalchuk, Tatyana N. Detkovskaya, Elena E. Andreeva
Publikováno v:
Viruses
Viruses, Vol 13, Iss 1648, p 1648 (2021)
Volume 13
Issue 8
Viruses, Vol 13, Iss 1648, p 1648 (2021)
Volume 13
Issue 8
The SARS-CoV-2 pandemic, which came to Russia in March 2020, is accompanied by morbidity level changes and can be tracked using serological monitoring of a representative population sample from Federal Districts (FDs) and individual regions. In a lon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd932c97f436683a29d3fe12e092f92e
http://europepmc.org/articles/PMC8402751
http://europepmc.org/articles/PMC8402751